It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Our aim was to assess whether airborne particle counting is an immediate indicator of biocontamination in controlled environment rooms with HEPA filters in a hospital. A prospective study was carried out in a tertiary care hospital between 2016 and 2018. The study was divided in two periods and the measurements were performed in different controlled environment rooms with HEPA filters. The Environmental Biosafety Criterion (EBC) was defined as the absence of fungal and bacterial contamination. In the training period, the area under the ROC curve (aROC) of airborne particle counting and EBC was calculated for each particle size as well as the cut-off points that optimize the combination of sensitivity and specificity in the association between them. aROC is created by plotting sensitivity against 1-specificity. In the testing period, the cut-off points previously selected were validated. 328 measurements were carried out in the training period and 301 in the testing period. In the training period, an association was found between airborne particle counting and EBC. An aROC = 0.760, 95% Confidence Interval (95% CI) 0.695–0.825 was observed for 0.3 µm particles; an aROC = 0.797 (95% CI 0.734–0.860) for 0.5 µm particles; and an aROC = 0.751 (95% CI 0.673–0.829) for 5 µm particles. The cut-off points that optimized the combination of sensitivity and specificity were 9.0 × 103 for 0.3 µm particles, 3.6 × 103 particles for 0.5 µm, and 3.2 × 102 particles for 5 µm. In the testing period, the previous cut-off points were validated. We conclude that airborne particle counting is a useful, immediate, and preliminary measure to identify the presence of biocontamination in controlled environment rooms with HEPA filters.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Hospital Universitario de La Princesa, Service of Preventive Medicine, Madrid, Spain (GRID:grid.411251.2) (ISNI:0000 0004 1767 647X)
2 Hospital Universitario de La Princesa, Service of Preventive Medicine, Madrid, Spain (GRID:grid.411251.2) (ISNI:0000 0004 1767 647X); Universidad Autónoma de Madrid-IdiPaz; and CIBERESP (CIBER of Epidemiology and Public Health), Department of Preventive Medicine and Public Health. School of Medicine, Madrid, Spain (GRID:grid.5515.4) (ISNI:0000000119578126)
3 Hospital Universitario de La Princesa, Service of Preventive Medicine, Madrid, Spain (GRID:grid.411251.2) (ISNI:0000 0004 1767 647X); Universidad Autónoma de Madrid-IdiPaz; and CIBERESP (CIBER of Epidemiology and Public Health), Department of Preventive Medicine and Public Health. School of Medicine, Madrid, Spain (GRID:grid.5515.4) (ISNI:0000000119578126); Harvard T.H. Chan School of Public Health, Department of Nutrition, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)